- Filed
- Apr 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Dec 31, 2024 | 224.38M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 220.91M sh |
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 224.34M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2024 | €101.85M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −€267.89M |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | €481.75M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | €402.45M |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | €696.61M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | €516.94M |
| Current Liabilities | FY 2024 · Dec 31, 2024 | €72.35M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | €186.39M |
| Total Liabilities | FY 2024 · Dec 31, 2024 | €106.22M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | €271.31M |
| Current Assets | FY 2024 · Dec 31, 2024 | €526.41M |
| Current Assets | FY 2024 · Dec 31, 2023 | €478.38M |
| Total Assets | FY 2024 · Dec 31, 2024 | €802.83M |
| Total Assets | FY 2024 · Dec 31, 2023 | €788.25M |
| Eps Diluted | FY 2024 · Dec 31, 2024 | €0.72 |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −€1.18 |
| Eps Basic | FY 2024 · Dec 31, 2024 | €0.72 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −€1.18 |
| Rd Expense | FY 2024 · Dec 31, 2024 | €153.03M |
| Rd Expense | FY 2024 · Dec 31, 2023 | €115.72M |
| Net Income | FY 2024 · Dec 31, 2024 | €162.19M |
| Net Income | FY 2024 · Dec 31, 2023 | −€260.17M |
| Operating Income | FY 2024 · Dec 31, 2024 | €177.68M |
| Operating Income | FY 2024 · Dec 31, 2023 | −€274.21M |
| Cost Of Revenue | FY 2024 · Dec 31, 2024 | €105.83M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | €124.37M |